| Literature DB >> 36147143 |
Maher Al-Hajjaj1, Aziz Joseph Sabbagh1, Ibrahim Al-Hadid1, Mohamed Taher Anan2, Mohammad Nour Kazan1, Ali Alali Aljool1, Hasan Al Muhammad Al Husein1, Mohamed Tallaa3.
Abstract
Background: Obstructive uropathy due to stone disease is seen every day in urological practice. Percutaneous nephrostomy and double j ureteral stent procedures are used. Methodology: A randomized controlled trial was conducted in one center from January 2021 to January 2022. A total of 104 patients of age ≥18 years who had unilateral or bilateral obstructive uropathy due to stone disease were divided into two groups. In Group A, 50 patients underwent to double j stent while in Group B, 54 patients who underwent percutaneous nephrostomy insertion tube. Under local anesthesia, the stent was inserted by cystoscopy. While the percutaneous nephrostomy was done under ultrasound guidance by using local anesthetic agent. Complications were noted in immediate postoperative period and on follow up.Entities:
Keywords: Double j stent; Nephrolithiasis; Nephrostomy; Obstructive uropathy
Year: 2022 PMID: 36147143 PMCID: PMC9486745 DOI: 10.1016/j.amsu.2022.104474
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Patients characteristics.
| DJ (n = 50) | PCN (n = 54) | P value | |
|---|---|---|---|
| Age (years) | 35.6 ± 12.7 | 36.7 ± 12.5 | 0.001 |
| Gender (Male) | 23 (46%) | 26(52%) | 0.826 |
| Hypertension | 13 (26%) | 15 (27.7%) | 0.838 |
| Diabetes Mellitus | 6 (12%) | 18 (33.3%) | 0.010 |
| Ischemic Heart Disease | 6 (12%) | 8 (14.8%) | 0.674 |
| Previous endourological procedures | 21 (42%) | 21 (38.8) | 0.747 |
| Scr before procedure (mg/dl) | 1.59 ± 1.37 | 1.50 ± 1.22 | 0.000 |
| Scr at discharge (mg/dl) | 1.53 ± 1.02 | 1.34 ± 1.06 | 0.000 |
| Scr at definite treatment (mg/dl) | 1.64 ± 1.35 | 1.19 ± 0.57 | 0.001 |
| Positive Urinalysis | 23 (46%) | 29 (53.7%) | 0.432 |
| Post Procedure hospitalization days | 2.67 ± 1.69 | 1.52 ± 1.37 | 0.023 |
| Days from 1st to 2nd operation | 20.17 ± 12.16 | 21.28 ± 8.94 | 0.040 |
Complications rate in both groups.
| Complications | Group A (n = 50) | Group B (n = 54) | ||
|---|---|---|---|---|
| No of Patients | % age | No of Patients | % age | |
| Procedure Failure | 03 | 6.0 | 01 | 1.8 |
| Fever & Septicemia | 04 | 8.0 | 02 | 3.7 |
| Bleeding/Hematuria | 08 | 16.0 | 03 | 5.5 |
| Painful Trigone Irrigation | 05 | 10.0 | __ | __ |
| PCN dislodgement or blockage | __ | __ | 03 | 5.5 |
| Ureteral Perforation | 00 | 0.0 | __ | __ |
| Stent Migration | 00 | 0.0 | __ | __ |
| Injury to adjacent organs | __ | 1 | 1.8 | |
| Stent Encrustation or Stone Formation | 02 | 4.0 | __ | __ |
| Total | 22 | 44.0 | 10 | 18.3 |
Fig. 1Initial and overall success rate in both groups.